442 related articles for article (PubMed ID: 31095586)
21. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.
Daehn I; Casalena G; Zhang T; Shi S; Fenninger F; Barasch N; Yu L; D'Agati V; Schlondorff D; Kriz W; Haraldsson B; Bottinger EP
J Clin Invest; 2014 Apr; 124(4):1608-21. PubMed ID: 24590287
[TBL] [Abstract][Full Text] [Related]
22. The FERM protein EPB41L5 regulates actomyosin contractility and focal adhesion formation to maintain the kidney filtration barrier.
Schell C; Rogg M; Suhm M; Helmstädter M; Sellung D; Yasuda-Yamahara M; Kretz O; Küttner V; Suleiman H; Kollipara L; Zahedi RP; Sickmann A; Eimer S; Shaw AS; Kramer-Zucker A; Hirano-Kobayashi M; Abe T; Aizawa S; Grahammer F; Hartleben B; Dengjel J; Huber TB
Proc Natl Acad Sci U S A; 2017 Jun; 114(23):E4621-E4630. PubMed ID: 28536193
[TBL] [Abstract][Full Text] [Related]
23. Direct effect of plasma permeability factors from patients with idiopatic FSGS on nephrin and podocin expression in human podocytes.
Doublier S; Musante L; Lupia E; Candiano G; Spatola T; Caridi G; Zennaro C; Carraro M; Ghiggeri GM; Camussi G
Int J Mol Med; 2005 Jul; 16(1):49-58. PubMed ID: 15942677
[TBL] [Abstract][Full Text] [Related]
24. Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis.
Müller-Deile J; Sarau G; Kotb AM; Jaremenko C; Rolle-Kampczyk UE; Daniel C; Kalkhof S; Christiansen SH; Schiffer M
Sci Rep; 2021 Feb; 11(1):4577. PubMed ID: 33633212
[TBL] [Abstract][Full Text] [Related]
25. Pathobiology of focal segmental glomerulosclerosis: new developments.
D'Agati VD
Curr Opin Nephrol Hypertens; 2012 May; 21(3):243-50. PubMed ID: 22357339
[TBL] [Abstract][Full Text] [Related]
26. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
[TBL] [Abstract][Full Text] [Related]
27. Pathophysiology of focal segmental glomerulosclerosis.
Reidy K; Kaskel FJ
Pediatr Nephrol; 2007 Mar; 22(3):350-4. PubMed ID: 17216262
[TBL] [Abstract][Full Text] [Related]
28. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children.
Srivastava T; Garola RE; Singh HK
Kidney Int; 2006 Aug; 70(3):529-35. PubMed ID: 16775597
[TBL] [Abstract][Full Text] [Related]
29. Morphologic Analysis of Urinary Podocytes in Focal Segmental Glomerulosclerosis.
Shirai Y; Miura K; Yokoyama T; Horita S; Nakayama H; Seino H; Ando T; Shiratori A; Yabuuchi T; Kaneko N; Ishiwa S; Ishizuka K; Hara M; Hattori M
Kidney360; 2021 Mar; 2(3):477-486. PubMed ID: 35369007
[TBL] [Abstract][Full Text] [Related]
30. New Anti-Nephrin Antibody Mediated Podocyte Injury Model Using a C57BL/6 Mouse Strain.
Takeuchi K; Naito S; Kawashima N; Ishigaki N; Sano T; Kamata K; Takeuchi Y
Nephron; 2018; 138(1):71-87. PubMed ID: 28965116
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y
Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861
[TBL] [Abstract][Full Text] [Related]
32. Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis.
Chang JW; Pardo V; Sageshima J; Chen L; Tsai HL; Reiser J; Wei C; Ciancio G; Burke GW; Fornoni A
Transplantation; 2012 Jun; 93(12):1238-44. PubMed ID: 22499148
[TBL] [Abstract][Full Text] [Related]
33. Reduced INF2 expression in nephrotic syndrome is possibly related to clinical severity of steroid resistance in children.
Tamura H; Nakazato H; Kuraoka S; Yoneda K; Takahashi W; Endo F
Nephrology (Carlton); 2016 Jun; 21(6):467-75. PubMed ID: 26383224
[TBL] [Abstract][Full Text] [Related]
34. SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process Maintenance.
Rogg M; Maier JI; Dotzauer R; Artelt N; Kretz O; Helmstädter M; Abed A; Sammarco A; Sigle A; Sellung D; Dinse P; Reiche K; Yasuda-Yamahara M; Biniossek ML; Walz G; Werner M; Endlich N; Schilling O; Huber TB; Schell C
J Am Soc Nephrol; 2021 Mar; 32(3):563-579. PubMed ID: 33514561
[TBL] [Abstract][Full Text] [Related]
35. Plasma microRNA panel is a novel biomarker for focal segmental glomerulosclerosis and associated with podocyte apoptosis.
Xiao B; Wang LN; Li W; Gong L; Yu T; Zuo QF; Zhao HW; Zou QM
Cell Death Dis; 2018 May; 9(5):533. PubMed ID: 29748623
[TBL] [Abstract][Full Text] [Related]
36. Podocyte protease activated receptor 1 stimulation in mice produces focal segmental glomerulosclerosis mirroring human disease signaling events.
May CJ; Chesor M; Hunter SE; Hayes B; Barr R; Roberts T; Barrington FA; Farmer L; Ni L; Jackson M; Snethen H; Tavakolidakhrabadi N; Goldstone M; Gilbert R; Beesley M; Lennon R; Foster R; Coward R; Welsh GI; Saleem MA
Kidney Int; 2023 Aug; 104(2):265-278. PubMed ID: 36940798
[TBL] [Abstract][Full Text] [Related]
37. Transcription factor MafB in podocytes protects against the development of focal segmental glomerulosclerosis.
Usui T; Morito N; Shawki HH; Sato Y; Tsukaguchi H; Hamada M; Jeon H; Yadav MK; Kuno A; Tsunakawa Y; Okada R; Ojima T; Kanai M; Asano K; Imamura Y; Koshida R; Yoh K; Usui J; Yokoi H; Kasahara M; Yoshimura A; Muratani M; Kudo T; Oishi H; Yamagata K; Takahashi S
Kidney Int; 2020 Aug; 98(2):391-403. PubMed ID: 32622525
[TBL] [Abstract][Full Text] [Related]
38. MAD2B-mediated cell cycle reentry of podocytes is involved in the pathogenesis of FSGS.
Bao D; Su H; Lei CT; Tang H; Ye C; Xiong W; He FF; Lin JH; Hammes HP; Zhang C
Int J Biol Sci; 2021; 17(15):4396-4408. PubMed ID: 34803506
[No Abstract] [Full Text] [Related]
39. Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.
Morita M; Mii A; Shimizu A; Yasuda F; Shoji J; Masuda Y; Ohashi R; Nagahama K; Kaneko T; Tsuruoka S
PLoS One; 2015; 10(4):e0116700. PubMed ID: 25875837
[TBL] [Abstract][Full Text] [Related]
40. AMPK mediates regulation of glomerular volume and podocyte survival.
Banu K; Lin Q; Basgen JM; Planoutene M; Wei C; Reghuvaran AC; Tian X; Shi H; Garzon F; Garzia A; Chun N; Cumpelik A; Santeusanio AD; Zhang W; Das B; Salem F; Li L; Ishibe S; Cantley LG; Kaufman L; Lemley KV; Ni Z; He JC; Murphy B; Menon MC
JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34473647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]